Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
-0.0202 (-97.12%)
Mar 31, 2025, 4:00 PM EST
Ampio Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
681.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 16.04M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.60M |
| American Oncology Network | 1.76B |
| Longduoduo Company | 6.01M |
Ampio Pharmaceuticals News
- 1 year ago - Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation - PRNewsWire
- 1 year ago - Ampio Announces Voluntary Delisting and SEC Deregistration - PRNewsWire
- 1 year ago - Ampio Provides Update on Results from Pre-IND Enabling Studies - PRNewsWire
- 1 year ago - Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals to Present at the Emerging Growth Conference - PRNewsWire
- 1 year ago - Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals Announces Reverse Stock Split - PRNewsWire
- 2 years ago - Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock - PRNewsWire